Post Tue Apr 25, 2023 9:06 pm

2021-Ho et al-Nat Cancer

"Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity"
Won Jin Ho, Qingfeng Zhu, Jennifer Durham, Aleksandra Popovic, Stephanie Xavier, James Leatherman, Aditya Mohan, Guanglan Mo, Shu Zhang, Nicole Gross, Soren Charmsaz, Dongxia Lin, Derek Quong, Brad Wilt, Ihab R Kamel, Matthew Weiss, Benjamin Philosophe, Richard Burkhart, William R Burns, Chris Shubert, Aslam Ejaz, Jin He, Atul Deshpande, Ludmila Danilova, Genevieve Stein-O'Brien, Elizabeth A Sugar, Daniel A Laheru, Robert A Anders, Elana J Fertig, Elizabeth M Jaffee, Mark Yarchoan
Nat Cancer. 2021, 2, 891-903
https://doi.org/10.1038/s43018-021-00234-4

- "Data availability The CyTOF datasets analyzed in this study have been deposited in FlowRepository (FR-FCM-Z34P). The imaging mass cytometry dataset has been deposited as part of the published Code Ocean capsule (https://doi.org/10.24433/CO.3769407.v2)."